FY2026 · period end Mar '26 · from the 10-K filed Jun 25, 2026
Data as filed with the SEC, provided for information only — not investment advice.
| Metric | FY26Mar '26 | FY25Mar '25 | FY24Mar '24 | FY23Mar '23 | FY22Mar '22 |
|---|---|---|---|---|---|
| Revenue | $0.01B | $0.01B | $0.00B | $0.00B | $0.00B |
| Gross Profit | — | — | — | $0.00B | $0.00B |
| Operating Income | $0.09B | negative: -$0.01B | negative: -$0.01B | negative: -$0.02B | negative: -$0.04B |
| Net Income | $0.09B | negative: -$0.01B | negative: -$0.01B | negative: -$0.02B | negative: -$0.04B |
| EPS (Diluted) | $4.83 | negative: -$0.61 | negative: -$0.49 | negative: -$0.87 | negative: -$2.07 |
| Metric | FY26Mar '26 | FY25Mar '25 | FY24Mar '24 | FY23Mar '23 | FY22Mar '22 |
|---|---|---|---|---|---|
| Total Assets | $0.47B | $0.33B | $0.32B | $0.28B | $0.28B |
| Total Liabilities | $0.20B | $0.18B | $0.16B | $0.10B | $0.09B |
| Stockholders' Equity | $0.26B | $0.16B | $0.16B | $0.18B | $0.19B |
| Cash & Equivalents | $0.10B | $0.05B | $0.06B | $0.04B | $0.11B |
| Total Debt | — | — | — | — | — |
| Metric | FY26Mar '26 | FY25Mar '25 | FY24Mar '24 | FY23Mar '23 | FY22Mar '22 |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.01B | negative: -$0.03B | $0.04B | negative: -$0.03B | $0.02B |
| Capital Expenditures | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Free Cash Flow | $0.01B | negative: -$0.03B | $0.04B | negative: -$0.03B | $0.02B |
| Metric | FY26Mar '26 | FY25Mar '25 | FY24Mar '24 | FY23Mar '23 | FY22Mar '22 |
|---|---|---|---|---|---|
| Gross Margin | — | — | — | 100.0% | 99.5% |
| Operating Margin | 1444.9% | negative: -1.9% | negative: -2.4% | negative: -8.6% | negative: -3399.3% |
| Net Margin | 1394.2% | negative: -1.9% | negative: -2.2% | negative: -8.5% | negative: -3461.2% |
| Return on Equity | 43.3% | negative: -7.2% | negative: -5.4% | negative: -8.9% | negative: -20.1% |
| Return on Assets | 22.7% | negative: -3.5% | negative: -3.0% | negative: -5.9% | negative: -13.5% |
| Debt / Equity | — | — | — | — | — |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or full history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001304492-26-000053 | Sep 16, 2026 | Sep 18, 2026 | Sep 18, 2026 20:29 UTC | EDGAR |
| 8-K | 0001304492-26-000045 | Aug 11, 2026 | Aug 11, 2026 | Aug 11, 2026 20:05 UTC | EDGAR |
| 10-Q | 0001304492-26-000046 | Jun 30, 2026 | Aug 11, 2026 | Aug 11, 2026 20:08 UTC | EDGAR |
| 8-K | 0001304492-26-000041 | Aug 4, 2026 | Aug 6, 2026 | Aug 6, 2026 20:51 UTC | EDGAR |
| 10-K | 0001304492-26-000027 | Mar 31, 2026 | Jun 25, 2026 | Jun 25, 2026 19:05 UTC | EDGAR |
| 8-K | 0001304492-26-000024 | Jun 10, 2026 | Jun 10, 2026 | Jun 10, 2026 20:45 UTC | EDGAR |
| 8-K | 0001304492-26-000019 | Apr 21, 2026 | Apr 21, 2026 | Apr 21, 2026 11:32 UTC | EDGAR |
| 8-K | 0001304492-26-000016 | Mar 31, 2026 | Apr 6, 2026 | Apr 6, 2026 11:31 UTC | EDGAR |
Direct links to SEC EDGAR. ATEX has additional filings available on the SEC site.
6 numbers Anterix Inc. later changed — same XBRL tag, both filings linked.
Net Income (Loss) Attributable to Parent·Q3 2017
Major restatementwas-$5.7M
Revised up in a 10-K.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest·Q2 2021
Major restatementwas-$11.9M
Revised up in a 10-Q.
Operating Income (Loss)·Q2 2021
Major restatementwas-$12M
Revised up in a 10-Q.
Net Income (Loss) Attributable to Parent·Q2 2021
Major restatementwas-$12M
Revised up in a 10-Q.
Net Cash Provided by (Used in) Operating Activities·Q1 2020
Major restatementwas-$4.6M
Revised down in a 10-Q.
Liabilities·As of Mar 31, 2018
Major restatementwas$17.9M
Revised down in a 10-K.
ATEX is not the only one.
See every restatement we've found across the market — or get an alert the next time ATEX revises a number.
Restatements are detected by comparing every vintage of a fact across all of Anterix Inc.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows ATEX's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling Anterix Inc. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on ATEX yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows on data pinned to its SEC filing. Be the first: run equity_research_brief on ATEX and publish the result to your public profile.
Ask about Anterix Inc.
Continue in Workspace — cited answers on ATEX, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate, with delisted companies kept in.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs